QGEN
NYSE
$40.53
Qiagen NV (QGEN)
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $44.07 (+8.73%)
Market Cap
$8.51B
PEG Ratio
0.05
Profit Margin
20.3%
Forward P/E
12.94
Price Chart
Valuation
Market Cap$8.51B
P/E20.03
Forward P/E12.94
PEG0.05
P/S4.08
P/B2.56
Profitability
Total Revenue (TTM)$2.09B
Gross Profit (TTM)$1.39B
EBITDA$660M
Profit Margin20.3%
Operating Margin22.3%
EPS$2.06
Financial Health
Debt-to-Equity43.8%
Free Cash Flow Yield5.33%
Dividend Yield0.77%
Growth & Risk
EPS 5Y CAGR+3.15%
Revenue 5Y CAGR+2.25%
FCF 5Y CAGR+6.88%
Beta (5Y)0.50
Sharpe Ratio-0.46